Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 181

1.

Characterization of nanoparticles for therapeutics.

Hall JB, Dobrovolskaia MA, Patri AK, McNeil SE.

Nanomedicine (Lond). 2007 Dec;2(6):789-803. Review.

PMID:
18095846
2.

Nanoparticle therapeutics: a personal perspective.

McNeil SE.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009 May-Jun;1(3):264-71. doi: 10.1002/wnan.6.

PMID:
20049796
3.

Radical nanomedicine.

Rzigalinski BA, Meehan K, Davis RM, Xu Y, Miles WC, Cohen CA.

Nanomedicine (Lond). 2006 Dec;1(4):399-412. Review.

PMID:
17716143
4.

Unique benefits of nanotechnology to drug delivery and diagnostics.

McNeil SE.

Methods Mol Biol. 2011;697:3-8. doi: 10.1007/978-1-60327-198-1_1.

PMID:
21116949
5.

Integration column: biofunctional polymeric nanoparticles for spatio-temporal control of drug delivery and biomedical applications.

Rothenfluh DA, Hubbell JA.

Integr Biol (Camb). 2009 Jul;1(7):446-51. doi: 10.1039/b907627c. Epub 2009 May 28. Review.

PMID:
20023754
6.

Functionalized gold nanoparticles for drug delivery.

Han G, Ghosh P, Rotello VM.

Nanomedicine (Lond). 2007 Feb;2(1):113-23. Review.

PMID:
17716197
7.

Nanomedicine: evolutionary and revolutionary developments in the treatment of certain inflammatory diseases.

Szelenyi I.

Inflamm Res. 2012 Jan;61(1):1-9. doi: 10.1007/s00011-011-0393-7. Epub 2011 Nov 5. Review.

PMID:
22057873
8.

Theranostic nanoparticles engineered for clinic and pharmaceutics.

Ma X, Zhao Y, Liang XJ.

Acc Chem Res. 2011 Oct 18;44(10):1114-22. doi: 10.1021/ar2000056. Epub 2011 Jul 6. Review.

PMID:
21732606
9.
10.

Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles.

Elnaggar YS, El-Massik MA, Abdallah OY.

Int J Nanomedicine. 2011;6:3195-205. doi: 10.2147/IJN.S25825. Epub 2011 Dec 6.

11.
12.
13.

Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.

Gaumet M, Vargas A, Gurny R, Delie F.

Eur J Pharm Biopharm. 2008 May;69(1):1-9. Epub 2007 Aug 7. Review.

PMID:
17826969
14.

Nanomedicine drug development: a scientific symposium entitled "Charting a roadmap to commercialization".

Finch G, Havel H, Analoui M, Barton RW, Diwan AR, Hennessy M, Reddy V, Sadrieh N, Tamarkin L, Wolfgang M, Yerxa B, Zolnik B, Liu M.

AAPS J. 2014 Jul;16(4):698-704. doi: 10.1208/s12248-014-9608-5. Epub 2014 May 13.

15.

Nanomedicine: sizing up targets with nanoparticles.

Minchin R.

Nat Nanotechnol. 2008 Jan;3(1):12-3. doi: 10.1038/nnano.2007.433. No abstract available.

PMID:
18654442
16.

A review of the current scientific and regulatory status of nanomedicines and the challenges ahead.

Hock SC, Ying YM, Wah CL.

PDA J Pharm Sci Technol. 2011 Mar-Apr;65(2):177-95. Review.

PMID:
21502077
17.

Therapeutic and diagnostic applications of nanoparticles.

Youns M, Hoheisel JD, Efferth T.

Curr Drug Targets. 2011 Mar 1;12(3):357-65. Review.

PMID:
20955146
18.

Nanomedicine: magnetic nanoparticles and their biomedical applications.

Banerjee R, Katsenovich Y, Lagos L, McIintosh M, Zhang X, Li CZ.

Curr Med Chem. 2010;17(27):3120-41. Review.

PMID:
20629620
19.

Nanomedicine: de novo design of nanodrugs.

Yang Z, Kang SG, Zhou R.

Nanoscale. 2014 Jan 21;6(2):663-77. doi: 10.1039/c3nr04535h. Review.

PMID:
24305636
20.

Supplemental Content

Support Center